DK2975022T3 - Hidtil ukendt hydroxaminsyrederivat eller salt deraf - Google Patents

Hidtil ukendt hydroxaminsyrederivat eller salt deraf Download PDF

Info

Publication number
DK2975022T3
DK2975022T3 DK14763168.3T DK14763168T DK2975022T3 DK 2975022 T3 DK2975022 T3 DK 2975022T3 DK 14763168 T DK14763168 T DK 14763168T DK 2975022 T3 DK2975022 T3 DK 2975022T3
Authority
DK
Denmark
Prior art keywords
salt
acid derivative
hydroxamic acid
new hydroxamic
new
Prior art date
Application number
DK14763168.3T
Other languages
English (en)
Inventor
Muneo Shoji
Naomi Sugaya
Naoko Yasobu
Original Assignee
Fujifilm Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Toyama Chemical Co Ltd filed Critical Fujifilm Toyama Chemical Co Ltd
Application granted granted Critical
Publication of DK2975022T3 publication Critical patent/DK2975022T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/04Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D305/08Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
DK14763168.3T 2013-03-15 2014-03-14 Hidtil ukendt hydroxaminsyrederivat eller salt deraf DK2975022T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013052798 2013-03-15
PCT/JP2014/056864 WO2014142298A1 (ja) 2013-03-15 2014-03-14 新規なヒドロキサム酸誘導体またはその塩

Publications (1)

Publication Number Publication Date
DK2975022T3 true DK2975022T3 (da) 2019-07-15

Family

ID=51536946

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14763168.3T DK2975022T3 (da) 2013-03-15 2014-03-14 Hidtil ukendt hydroxaminsyrederivat eller salt deraf

Country Status (17)

Country Link
US (1) US9862676B2 (da)
EP (1) EP2975022B1 (da)
JP (1) JP6259814B2 (da)
CN (1) CN105073710B (da)
CA (1) CA2905248A1 (da)
CY (1) CY1121626T1 (da)
DK (1) DK2975022T3 (da)
ES (1) ES2728336T3 (da)
HR (1) HRP20191026T1 (da)
HU (1) HUE043922T2 (da)
LT (1) LT2975022T (da)
PL (1) PL2975022T3 (da)
PT (1) PT2975022T (da)
RS (1) RS58930B1 (da)
SI (1) SI2975022T1 (da)
TR (1) TR201911245T4 (da)
WO (1) WO2014142298A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014306451B2 (en) * 2013-08-16 2019-01-17 Duke University Substituted hydroxamic acid compounds
CA2960936A1 (en) * 2014-09-12 2016-03-17 Toyama Chemical Co., Ltd. Method for using novel hydroxamic acid derivative and antibacterial substance in combination
CN106794160A (zh) * 2014-09-12 2017-05-31 富山化学工业株式会社 含有新的氧肟酸衍生物或其盐的药物组合物
WO2017170884A1 (ja) * 2016-03-31 2017-10-05 富山化学工業株式会社 新規なヒドロキサム酸誘導体の製造方法およびその中間体
EP3438088A4 (en) * 2016-03-31 2019-04-17 FUJIFILM Toyama Chemical Co., Ltd. CRYSTALS OF A NEW HYDROXAMIC ACID DERIVATIVE, PROCESS FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION
WO2018143162A1 (ja) 2017-01-31 2018-08-09 富山化学工業株式会社 ヒドロキサム酸のプロドラッグである化合物またはその塩、凍結乾燥製剤、LpxC阻害剤および抗菌剤
CN110963907B (zh) * 2019-12-05 2023-12-19 中国农业科学院植物保护研究所 一种2,2-二烷氧基苯乙酮衍生物的绿色合成
CN117769548A (zh) 2021-08-05 2024-03-26 浙江海正药业股份有限公司 芳香乙炔类衍生物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062601A2 (en) * 2003-01-08 2004-07-29 Chiron Corporation Antibacterial agents
EP1963262A2 (en) 2005-12-15 2008-09-03 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
EP2170814B1 (en) 2007-06-12 2016-08-17 Achaogen, Inc. Antibacterial agents
WO2010017060A1 (en) 2008-08-04 2010-02-11 Schering Corporation Urea derivatives as antibacterial agents
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
CA2735929C (en) 2008-09-19 2013-12-17 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
KR101826371B1 (ko) 2010-04-20 2018-02-06 다이쇼 세이야꾸 가부시끼가이샤 신규 히드록삼산 유도체
US9738604B2 (en) * 2010-09-03 2017-08-22 Duke University Ethynylbenzene derivatives
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
JP2016210683A (ja) * 2013-10-18 2016-12-15 大正製薬株式会社 ヒドロキサム酸誘導体
JP2016210682A (ja) * 2013-10-18 2016-12-15 大正製薬株式会社 ヒドロキサム酸誘導体

Also Published As

Publication number Publication date
US20160039751A1 (en) 2016-02-11
JPWO2014142298A1 (ja) 2017-02-16
EP2975022B1 (en) 2019-05-08
RS58930B1 (sr) 2019-08-30
EP2975022A1 (en) 2016-01-20
EP2975022A4 (en) 2016-10-12
PT2975022T (pt) 2019-06-11
JP6259814B2 (ja) 2018-01-10
HUE043922T2 (hu) 2019-09-30
US9862676B2 (en) 2018-01-09
TR201911245T4 (tr) 2019-08-21
CN105073710A (zh) 2015-11-18
HRP20191026T1 (hr) 2019-10-18
SI2975022T1 (sl) 2019-08-30
PL2975022T3 (pl) 2019-11-29
CN105073710B (zh) 2018-02-16
ES2728336T3 (es) 2019-10-23
CY1121626T1 (el) 2020-07-31
CA2905248A1 (en) 2014-09-18
WO2014142298A1 (ja) 2014-09-18
LT2975022T (lt) 2019-07-25

Similar Documents

Publication Publication Date Title
NO2023046I1 (no) Futibatinib eller et salt derav
DK3043712T3 (da) Hjerteovervågningssystem
DK3201206T3 (da) Borsyrederivater
CL2014000410S1 (es) Ganchos
DK3083554T3 (da) Dimethylbenzoesyreforbindelser
DK2975022T3 (da) Hidtil ukendt hydroxaminsyrederivat eller salt deraf
CL2016001152A1 (es) Vacuna para peces
TH162626B (th) เกลือแคมซิลเลต
TH1401007860A (th) สารประกอบไดเมธิล-เบนโซอิค แอซิด
DK3283066T3 (da) 4-Phenylsmørsyrederivater
BR302013006436S1 (pt) Configuração aplicada em solado
BR302013005852S1 (pt) Configuração aplicada em solado
ES1085279Y (es) Estructura para toldos
BR302013005771S1 (pt) Configuração aplicada em solado
BR302013005770S1 (pt) Configuração aplicada em solado
BR302013005767S1 (pt) Configuração aplicada em solado
BR302013005769S1 (pt) Configuração aplicada em solado
BR302013005446S1 (pt) Configuração aplicada em solado
BR302013005470S1 (pt) Configuração aplicada em solado
BR302013005302S1 (pt) Configuração aplicada em solado
ES1079026Y (es) Candelabro para tanatorio o similar
BR302013001901S1 (pt) Configuração aplicada em solado
BR302013001260S1 (pt) Configuração aplicada em solado
BR302013000983S1 (pt) Configuração aplicada em solado
FI10300U1 (fi) Uistin